Avantor Inc (AVTR)

Currency in USD
16.69
-0.44(-2.57%)
Closed·
16.30-0.39(-2.34%)
·
AVTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.1717.22
52 wk Range
7.2717.45
Key Statistics
Prev. Close
16.69
Open
16.41
Day's Range
16.17-17.22
52 wk Range
7.27-17.45
Volume
29.72M
Average Volume (3m)
9.35M
1-Year Change
44.1278%
Book Value / Share
8.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVTR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.96
Downside
-4.36%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Avantor Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

2 Buy
12 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 15.96
(-4.36% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Hold17.00+1.86%14.00MaintainOct 28, 2026
TD Cowen
Hold17.00+1.86%15.00MaintainOct 13, 2026
Morgan Stanley
Hold15.00-10.13%14.00MaintainOct 13, 2026
Baird
Buy17.00+1.86%16.00MaintainOct 08, 2026
Barclays
Sell15.00-10.13%13.00MaintainOct 07, 2026

Avantor Inc SWOT Analysis


Market Challenges
Explore Avantor's navigation through sector headwinds, balancing strong Labs performance against Biopro division struggles in a competitive landscape
Leadership Transition
Delve into the implications of CEO Michael Stubblefield's departure and its potential impact on Avantor's strategic direction and market positioning
Financial Resilience
Discover Avantor's financial health with a $8.74B market cap, P/E ratio of 12.61, and strong gross margins of 33.25%, despite recent market challenges
Future Prospects
Analyst targets range from $13 to $31, reflecting diverse views on Avantor's recovery potential and long-term growth in the life sciences industry
Read full SWOT analysis

Avantor Inc Earnings Call Summary for Q3/2026

  • Avantor posted Q3 2026 revenue of $1.7B and adjusted EPS of $0.22, beating estimates of $1.64B and $0.21; shares fell 2.51% in premarket trading.
  • Organic revenue grew 5.2%, marking return to growth after decline; VWR segment up 5.8%, Bioscience & Medtech up 3.6% organically.
  • Company raised full-year guidance: organic revenue growth to 0.75%-1.25%, adjusted EPS to $0.81-$0.83, free cash flow to $525M-$550M.
  • Net debt fell $173M to $3.24B; adjusted net leverage improved to 3.1x from 3.3x, targeting below 3.0x by year-end.
  • Revival turnaround program gaining traction; pricing remains below inflation pressuring margins; Europe weak; investor day scheduled December 8.
Last Updated: 2026-10-28, 09:16 a/m
Read Full Transcript

Earnings

Latest Release
Oct 28, 2026
EPS / Forecast
0.22 / 0.21
Revenue / Forecast
1.7B / 1.64B
EPS Revisions
Last 90 days

AVTR Income Statement

Compare AVTR to Peers and Sector

Metrics to compare
AVTR
Peers
Sector
Relationship
P/E Ratio
−19.5x−0.4x−0.3x
PEG Ratio
0.110.000.00
Price/Book
2.0x1.6x2.6x
Price / LTM Sales
1.7x3.0x2.9x
Upside (Analyst Target)
−7.1%77.9%60.1%
Fair Value Upside
Unlock6.4%8.3%Unlock

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
369.86M54.68%6.39B
Other Institutional Investors
339.38M45.32%5.87B
Public Companies & Retail Investors
0.000.00%0.00
Total
709.24M100.00%12.26B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dodge & Cox17.75%120,020,9742,075,163
Dodge & Cox Funds - Dodge & Cox Stock Fund11.07%74,871,7151,294,532

People Also Watch

16.09
XP
+0.81%
28.80
CHYM
+0.88%
24.27
RELY
+0.25%
214.16
ICLR
+17.04%

FAQ

What Is the Avantor (AVTR) Stock Price Today?

The Avantor stock price today is 16.69 USD.

What Stock Exchange Does Avantor Trade On?

Avantor is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Avantor?

The stock symbol for Avantor is "AVTR."

What Is the Avantor Market Cap?

As of today, Avantor market cap is 11.29B USD.

What Is Avantor's Earnings Per Share (TTM)?

The Avantor EPS (TTM) is -0.85.

When Is the Next Avantor Earnings Date?

Avantor will release its next earnings report on Feb 04, 2027.

From a Technical Analysis Perspective, Is AVTR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Avantor Stock Split?

Avantor has split 0 times.

How Many Employees Does Avantor Have?

Avantor has 13500 employees.

What is the current trading status of Avantor (AVTR)?

As of Oct 29, 2026, Avantor (AVTR) is trading at a price of 16.69 USD, with a previous close of 16.69 USD. The stock has fluctuated within a day range of 16.17 USD to 17.22 USD, while its 52-week range spans from 7.27 USD to 17.45 USD.

What Is Avantor (AVTR) Price Target According to Analysts?

The average 12-month price target for Avantor is 15.96 USD, with a high estimate of 19 USD and a low estimate of 13 USD. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -4.36% Downside potential.

What Is the AVTR After Hours Price?

AVTR's last after hours stock price is 16.30 USD, the stock has decreased by -0.39, or -2.34%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.